Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 24 February 2027
- Last conf. stmt
- 10 February 2026
Amo Pharma Limited
- Incorporated
- 10 February 2015 (11 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- John BatesonMartin Doyle Mcnulty Jr.Alan Louis Rubino
- Controlled by
- Dermot Desmond
- Accounts type
- Total exemption full
- Region
- Yorkshire
- Address
- 1 Park RowLeedsLS1 5AB
Charges
- Total
- 4
- Outstanding
- 4
- Part satisfied
- 0
- Satisfied
- 0
Officers 4 active
Officer details are public data from the Companies House register.
Bateson, John
Director · Appointed 8 May 2024
Irish
Born July 1963 (63)
Mcnulty, Martin Doyle, Jr
Director · Appointed 8 May 2024
American
Born January 1978 (48)
Rubino, Alan Louis
Director · Appointed 16 August 2021
American
Born June 1954 (72)
Director · Appointed 10 February 2015
Also at Circadian Therapeutics Limited
British
Born April 1963 (63)
Officer history (5 former)
21 May 2025
21 March 2025
Resigned Horrigan, Joseph as Director
8 May 2024
Appointed Mcnulty, Martin Doyle, Jr as Director
8 May 2024
Appointed Bateson, John as Director
2 May 2024
23 September 2021
16 August 2021
Appointed Rubino, Alan Louis as Director
12 August 2021
Resigned Williams, Martyn as Director
30 November 2016
Resigned Wittmer, Lisa as Director
21 December 2015
Appointed Wittmer, Lisa as Director
21 December 2015
Appointed Horrigan, Joseph as Director
26 June 2015
8 June 2015
Appointed Williams, Martyn as Director
10 February 2015
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Dermot Desmond
Individual · Notified 4 February 2020
Has significant influence or control
Irish
Born August 1950 (76)
Holdings 2
Companies where Amo Pharma Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Former controllers (2)
4 February 2020
Ceased Iiu Nominees Limited — Has significant influence or control
8 January 2020
Ceased Woodford Patient Capital Trust PLC — Owns 25–50% of shares
Financials
Balance sheet as at 31 December 2025 · total exemption full accounts
- Cash
- £348,940
- Profit Before Tax
- (£6,308,273)
- Current Ratio
- 0.0x
Trend
Cash
Balance sheet detail
| 2025 | 2024 | |
|---|---|---|
| Fixed Assets | £663 | £1,939 |
| Current Assets | £2,073,726 | £2,697,196 |
| Debtors | £1,724,786 | £2,541,697 |
| Cash | £348,940 | £155,499 |
| Creditors (< 1 year) | £51,503,078 | |
| Net Current Assets | (£49,429,352) | (£44,135,170) |
| Net Assets | (£44,133,231) | |
| Shareholder Funds | (£49,428,689) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 July 2026 | Total exemption full accounts | 31 December 2025 | ||
| 1 June 2026 | Registration of a charge | |||
| 4 March 2026 | Confirmation statement with updates | 10 February 2026 | ||
| 12 August 2025 | Memorandum and Articles of Association | |||
| 12 August 2025 | Resolutions |
Some other companies at this address
Other companies in this industry
Stevenage
Reading
Didcot
London
Sandwich
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →